- Home
- STRO vs FRST Comparison
STRO vs FRST Comparison
Compare STRO & FRST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- FRST
- Stock Information
- Founded
- STRO 2003
- FRST 2004
- Country
- STRO United States
- FRST United States
- Employees
- STRO N/A
- FRST N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- FRST Major Banks
- Sector
- STRO Health Care
- FRST Finance
- Exchange
- STRO Nasdaq
- FRST Nasdaq
- Market Cap
- STRO 74.3M
- FRST 273.3M
- IPO Year
- STRO 2018
- FRST 2006
- Fundamental
- Price
- STRO $0.90
- FRST $11.13
- Analyst Decision
- STRO Hold
- FRST Buy
- Analyst Count
- STRO 7
- FRST 1
- Target Price
- STRO $1.97
- FRST $420.00
- AVG Volume (30 Days)
- STRO 523.1K
- FRST 61.9K
- Earning Date
- STRO 11-12-2025
- FRST 10-23-2025
- Dividend Yield
- STRO N/A
- FRST 3.62%
- EPS Growth
- STRO N/A
- FRST N/A
- EPS
- STRO N/A
- FRST 0.11
- Revenue
- STRO $104,473,000.00
- FRST $127,561,000.00
- Revenue This Year
- STRO $65.48
- FRST $13.42
- Revenue Next Year
- STRO N/A
- FRST $13.48
- P/E Ratio
- STRO N/A
- FRST $99.65
- Revenue Growth
- STRO N/A
- FRST 19.27
- 52 Week Low
- STRO $0.52
- FRST $7.59
- 52 Week High
- STRO $4.60
- FRST $12.95
- Technical
- Relative Strength Index (RSI)
- STRO 50.46
- FRST 52.16
- Support Level
- STRO $0.83
- FRST $10.91
- Resistance Level
- STRO $1.01
- FRST $11.05
- Average True Range (ATR)
- STRO 0.09
- FRST 0.25
- MACD
- STRO -0.01
- FRST -0.02
- Stochastic Oscillator
- STRO 20.80
- FRST 54.88
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About FRST Primis Financial Corp.
Primis Financial Corp is the bank holding company for Primis Bank, providing financial services to individuals and small and medium-sized businesses. Primis Bank offers a wide range of commercial banking services, It focuses on making loans secured mainly by commercial real estate and other types of secured and unsecured commercial loans to small and medium-sized businesses in several industries, as well as loans to individuals for a variety of purposes. Primis Bank offers a broad range of deposit products, including checking (NOW), savings, money market accounts, and certificates of deposit. Its operating segments are Primis Mortgage, Primis Bank, and Other.